PEG-hemoglobin: effects on tumor oxygenation and response to chemotherapy.
Teicher B, Ara G, Herbst R, Takeuchi H, Keyes S, Northey D. PEG-hemoglobin: effects on tumor oxygenation and response to chemotherapy. In Vivo 1997, 11: 301-11. PMID: 9292296.Peer-Reviewed Original ResearchConceptsPEG-hemoglobinTumor growth delayMammary carcinomaTumor cell killingSolid tumorsTumor oxygenationGrowth delayDose of chemotherapyEMT-6 murine mammary carcinomaBone marrow CFU-GMEfficacy of chemotherapyEMT-6 tumorsMurine mammary carcinomaTumor-bearing miceCFU-GM survivalMarrow CFU-GMCell killingOxygen delivery agentEMT-6 tumor-bearing miceChemotherapy administrationLung metastasesMultiple dosesSingle dosesChemotherapyCFU-GMProstate carcinoma response to cytotoxic therapy: in vivo resistance.
Teicher BA, Kakeji Y, Ara G, Herbst RS, Northey D. Prostate carcinoma response to cytotoxic therapy: in vivo resistance. In Vivo 1997, 11: 453-61. PMID: 9509295.Peer-Reviewed Original ResearchConceptsPC-3 tumorsDU-145 tumorsTGF-beta mRNAPC-3 cellsDU-145 cellsLNCaP tumorsSingle dosesAndrogen-independent prostate cancerChemotherapy-resistant diseaseHuman prostate carcinoma cell linesConcentrations of melphalanIndependent prostate cancerProstate carcinoma cell linesProstate carcinoma xenograftsCytotoxic cancer therapyCell linesProstate cell linesVivo high levelsTime-dependent increaseChemotherapy administrationResistant diseaseCarcinoma cell linesCytotoxic therapyPlasma levelsCarcinoma response